Literature DB >> 14839246

Use of cortisone in diseases of the eye.

F S LAVERY, L E WERNER, D O'DONOGHUE, P M GUINAN, J MACDOUGALD.   

Abstract

Entities:  

Keywords:  CORTISONE; EYES

Mesh:

Substances:

Year:  1951        PMID: 14839246      PMCID: PMC2069158          DOI: 10.1136/bmj.1.4718.1285

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  Clinical and experimental observation on the use of ACTH and cortisone in ocular inflammatory disease.

Authors:  A C WOODS
Journal:  Am J Ophthalmol       Date:  1950-09       Impact factor: 5.258

2.  Subconjunctival injection of cortisone in iritis.

Authors:  R KOFF; S ROME; R KASPER; R R COMMONS; R BUTTON; P STARR
Journal:  J Am Med Assoc       Date:  1950-12-09

3.  The experimental use of cortisone in inflammatory eye disease.

Authors:  E H STEFFENSEN; J A OLSON; R R MARGULIS; R W SMITH; E L WHITNEY
Journal:  Am J Ophthalmol       Date:  1950-07       Impact factor: 5.258

4.  Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions.

Authors:  P S HENCH; E C KENDALL; C H SLOCUMB; H F POLLEY
Journal:  Arch Intern Med (Chic)       Date:  1950-04

5.  Clinical observations on the use of cortisone in ophthalmic diseases: preliminary report.

Authors:  J W HENDERSON
Journal:  Proc Staff Meet Mayo Clin       Date:  1950-08-02
  5 in total
  4 in total

1.  Macular degeneration treated with cortisone.

Authors:  H E HOBBS
Journal:  Proc R Soc Med       Date:  1953-03

2.  Possible applications of adrenocorticotrophic hormone (ACTH) and cortisone in syphilis.

Authors:  G O HORNE
Journal:  Br J Vener Dis       Date:  1952-09

3.  The clinical value of cortisone and ACTH in ocular disease; a preliminary assessment for the Medical Research Council.

Authors:  S DUKE-ELDER
Journal:  Br J Ophthalmol       Date:  1951-11       Impact factor: 4.638

4.  Recurrent choroiditis treated with cortisone.

Authors:  P M GUINAN
Journal:  Br J Ophthalmol       Date:  1951-07       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.